Clal Biotechnology Industries Ltd. - Net Worth and Insider Trading

Clal Biotechnology Industries Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Clal Biotechnology Industries Ltd. owns 4 companies in total, including Neon Therapeutics Inc (NTGN) , Anchiano Therapeutics Ltd (CMMB) , and Chemomab Therapeutics Ltd (CMMB) among others .

Click here to see the complete history of Clal Biotechnology Industries Ltd.’s form 4 insider trades.

Insider Ownership Summary of Clal Biotechnology Industries Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
NTGN	Neon Therapeutics Inc	2020-03-23	other: See Remarks
CMMB	Anchiano Therapeutics Ltd	2020-01-01	10 percent owner
CMMB	Chemomab Therapeutics Ltd	2020-01-01	10 percent owner
		2022-01-01	other: Affiliate of 10% Owner

Clal Biotechnology Industries Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Clal Biotechnology Industries Ltd. Ownership Network

Ownership Network List of Clal Biotechnology Industries Ltd.

No Data

Ownership Network Relation of Clal Biotechnology Industries Ltd.

Clal Biotechnology Industries Ltd. Owned Company Details

What does Neon Therapeutics Inc do?

Who are the key executives at Neon Therapeutics Inc?

Clal Biotechnology Industries Ltd. is the other: See Remarks of Neon Therapeutics Inc. Other key executives at Neon Therapeutics Inc include President of R&D Richard Gaynor , director & 10 percent owner Robert I Tepper , and Chief Financial Officer Yasir B. Al-wakeel .

Neon Therapeutics Inc (NTGN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neon Therapeutics Inc (NTGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neon Therapeutics Inc (NTGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neon Therapeutics Inc (NTGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neon Therapeutics Inc Insider Transactions

No Available Data

What does Anchiano Therapeutics Ltd do?

Who are the key executives at Anchiano Therapeutics Ltd?

Clal Biotechnology Industries Ltd. is the 10 percent owner of Anchiano Therapeutics Ltd. Other key executives at Anchiano Therapeutics Ltd include Chief Financial Officer Stephen J. Dipalma , other: Affiliate of 10% Owner Len Blavatnik , and 10 percent owner Access Industries Holdings Llc .

Anchiano Therapeutics Ltd (CMMB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Anchiano Therapeutics Ltd (CMMB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anchiano Therapeutics Ltd (CMMB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anchiano Therapeutics Ltd (CMMB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Anchiano Therapeutics Ltd Insider Transactions

No Available Data

What does Chemomab Therapeutics Ltd do?

Who are the key executives at Chemomab Therapeutics Ltd?

Clal Biotechnology Industries Ltd. is the 10 percent owner of Chemomab Therapeutics Ltd. Other key executives at Chemomab Therapeutics Ltd include 10 percent owner Orbimed Israel Biofund Gp Limited Partnership , director & 10 percent owner & Chief Executive Officer George Adi Mor , and Chief Medical Officer Matthew Bejosa Frankel .

Chemomab Therapeutics Ltd (CMMB) Insider Trades Summary

Over the past 18 months, Clal Biotechnology Industries Ltd. made no insider transaction in Chemomab Therapeutics Ltd (CMMB). Other recent insider transactions involving Chemomab Therapeutics Ltd (CMMB) include a net sale of 582,023 shares made by George Adi Mor , a net sale of 336,900 shares made by Orbimed Israel Biofund Gp Limited Partnership , and a net sale of 2,409 shares made by Neil Harris Cohen .

In summary, during the past 3 months, insiders sold 0 shares of Chemomab Therapeutics Ltd (CMMB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 921,332 shares of Chemomab Therapeutics Ltd (CMMB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 921,332 shares.

Chemomab Therapeutics Ltd (CMMB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chemomab Therapeutics Ltd Insider Transactions

No Available Data

What does Gamida Cell Ltd do?

Who are the key executives at Gamida Cell Ltd?

Clal Biotechnology Industries Ltd. is the other: Affiliate of 10% Owner of Gamida Cell Ltd. Other key executives at Gamida Cell Ltd include Chief Financial Officer Mary Theresa Coelho , CMO & Chief Scientific Officer Ronit Simantov , and director & President and CEO Abigail L. Jenkins .

Gamida Cell Ltd (GMDAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Gamida Cell Ltd (GMDAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Gamida Cell Ltd (GMDAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Gamida Cell Ltd (GMDAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Gamida Cell Ltd Insider Transactions

No Available Data

Clal Biotechnology Industries Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Clal Biotechnology Industries Ltd.. You might contact Clal Biotechnology Industries Ltd. via mailing address: 3azrieli Center Triangle Tower 45 Floor, Tel Aviv L3 67023.

Discussions on Clal Biotechnology Industries Ltd.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.